1. Introduction {#sec1}
===============

Schizophrenia is a disorder often characterized by positive, cognitive, and negative symptoms ([@bb0048]), which may have different neurobiological bases ([@bb0054]; [@bb0057]). The positive (psychotic or thought disorder) symptoms may include hallucinations, delusions, and paranoia. The cognitive symptoms may include a failure to maintain attention, and deficits in short-term memory which is required to maintain attention. The negative symptoms may include reduced emotion and motivation, including reduced hedonia. The neuroleptic drugs, which include the phenothiazines such as chlorpromazine and the second generation drugs such as clozapine and olanzapine, treat mainly the positive symptoms. There is little evidence that treatment with neuroleptics substantially improves functional recovery (measured for example by whether the patient is in employment) for most people with schizophrenia ([@bb008]; [@bb0031]; [@bb0047]). This may be partly because neuroleptic drugs are not very effective in improving the cognitive and negative symptoms of schizophrenia ([@bb0044]). In this study, we aimed at identifying neurophysiological deficits in schizophrenia which are resistant to current anti-psychotic drugs. Identifying these key deficits which are present in schizophrenia, and which remain untreated by neuroleptics, is the fundamental approach that we take in this paper, to help provide insights into possible targets for new therapy for schizophrenia, which may help towards a better functional recovery than is obtained currently with neuroleptic drugs.

The etiology and neuropathophysiological mechanism of this debilitating and severe disorder still remain unclear. Over the last two decades, much neurophysiological evidence for structural and functional deficits in the brain in schizophrenia has been developed into a disconnectivity hypothesis ([@bb0022]). More direct evidence for the neurophysiological disconnectivity hypothesis comes mainly from functional Magnetic Resonance Imaging (fMRI) studies, particularly resting-state fMRI studies ([@bb0036]; [@bb0060]), which have shown widespread functional disconnectivity in distributed brain networks in schizophrenia. However, these studies have so far not revealed a consistent pattern ([@bb007]; [@bb0046]; [@bb0069]; [@bb0071]).

The reason for the inconsistency of the functional disconnectivity in schizophrenia still remains unclear. It has been suggested that this may be predominantly accounted for by medication effects and methodological differences in functional connectivity (FC) analysis ([@bb001]; [@bb0029]; [@bb0051]; [@bb0062]; [@bb0064]). There has been direct evidence that dopamine receptor antagonists can alter FC and brain network parameters ([@bb001]; [@bb0029]), suggesting that antipsychotics may be a major confounding factor in the FC analysis in schizophrenia patients. Thus, patterns of functional disconnectivity in neuroleptic-naïve schizophrenia (NNS) and neuroleptic-treated schizophrenia (NTS) patients might be in part different due to the neuroleptic treatment, but also partly similar owing to the limited efficiency of current antipsychotics in treating all symptoms of schizophrenia ([@bb008]; [@bb0031]; [@bb0047]). One of the aims of the current investigation was therefore to examine the common and the different features of brain functional disconnectivity in untreated (NNS) and neuroleptic treated (NTS) patients with schizophrenia, and this is one of the first studies to perform this.

2. Methods {#sec2}
==========

2.1. Participants {#sec2.1}
-----------------

The participants were 22 first-episode neuroleptic-naïve schizophrenic (NNS) patients and 61 first-episode neuroleptic-treated schizophrenia (NTS) patients recruited from the Department of Psychiatry of the Second Xiangya Hospital of Central South University, Changsha, China. All the patients met the DSM-IV diagnostic criteria for schizophrenia, Patient version (SCID-I/P) ([@bb0018]) (inclusion criteria and clinical measures for the patients are provided in the [Appendix](#s2105){ref-type="sec"}). The patient groups were not selected to be different, with the NNS patients recruited for the study in the outpatient department before they were administered drugs. The symptoms of the patients were evaluated using the Positive and Negative Symptoms Scale (PANSS) ([@bb0034]) by three psychiatrists in our research team. Sixty healthy controls (HC) were recruited from the communities of Changsha, China. The inclusion and exclusion criteria for HC were the same as those for the schizophrenic patients other than the DSM-IV diagnostic criteria. Individuals with a family history of psychiatric illness among their first-degree relatives were excluded from the HC group.

All participants gave their written informed consent to participate in the study after the risks and benefits were discussed in detail. The study was approved by the ethics committee of the Second Xiangya Hospital, Central South University.

2.2. Construction and comparison of the whole-brain functional connectivity network {#sec2.2}
-----------------------------------------------------------------------------------

After the resting-state fMRI data preprocessing (the fMRI data acquisition and preprocessing are described in the [Appendix](#s2105){ref-type="sec"}), the whole brain was parcellated into 90 regions of interest (ROIs) according to the automated anatomical labeling (AAL) atlas ([@bb0065]) (45 regions in each hemisphere, given in [Table S1](#t1005){ref-type="table"} in the [Appendix](#s2105){ref-type="sec"}), and the time series were extracted in each ROI by averaging the signals of all voxels within that region, and then linearly regressing out the influence of head motion and global signals. A correlation matrix for the functional connectivities was obtained for each subject. We calculated partial correlation coefficients because these remove the effect of any common input from all other brain regions. By calculating partial correlation coefficients between all pairs of ROIs, with all the remaining ROIs being controlling variables, a 90 × 90 correlation matrix was obtained for each subject. \[In more detail, we used a triplets-ROI based partial-correlation approach to remove the mediation from third-party regions. For an arbitrary pair of regions i and j, its partial correlation is calculated multiple times, each time with one third party region k (k = 1, 2, ..., 90, k ≠ i and k ≠ j) being controlled (i.e. the mediation from region k is removed). We call these 3 regions i, j and k a triplet in this case. Since there are altogether 90 brain regions, there will be 88 third-party mediators for i and j (i.e. 88 triplets), and thus 88 partial-correlation coefficients will be obtained for region pair i and j. We then pick the smallest one (in amplitude) as the partial-correlation coefficient between i and j ([@bb0024]; [@bb0064]), indicating that the largest influence among all third-party mediators is removed.\] This matrix was binarized to facilitate further statistical analyses by producing a sparse connectivity matrix by setting to 1 all links in the matrix with p \< 0.01, and to 0 otherwise. The sparsity values of the HC, NTS and NNS matrices produced by the use of the p \< 0.01 criterion were 2.15%, 2.27%, 2.17% respectively. The use of this criterion of p \< 0.01 can be supported in part because these sparsities are close to those of the sparsity of brain network connectivity as measured with diffusion tensor imaging ([@bb0025]). The use of this p \< 0.01 criterion is also justified by our prior work, which shows that the links that are significantly different between patient groups identified with this approach are robust to variation of the p \< 0.01 criterion within a range of 0.01--0.1 ([@bb0032]). Further discussion of the approach is provided elsewhere ([@bb0011]).

2.3. Measures of functional connectivity effects {#sec2.3}
------------------------------------------------

We used a risk difference approach, widely used in medical statistics ([@bb0039]; [@bb0068]), to test whether the binarized connectivity matrices were different between the patient and control groups. The effect associated with a particular link can be calculated from the following (risk difference) score ([@bb0064]):

$S^{\mathit{link}} = \frac{L_{p}^{\mathit{link}}}{N_{p}^{\mathit{link}}} - \frac{L_{h}^{\mathit{link}}}{N_{h}^{\mathit{link}}}$

where $S^{link}$ is the score for a particular link, $L_{h}^{link}$ is the number of links with a value of 1 in the population of healthy controls, $N_{h}^{link}$ is the total number of healthy controls, $L_{p}^{link}$ is the number of links with a value of 1 in the population of schizophrenics, and $N_{p}^{link}$ is the total number of patients. A risk difference of 0 indicates that the link is equally likely to occur in both groups, a risk difference score greater than 0 indicates that the link is more likely to occur (i.e. to be 1) in the patient group than in the control group, and a score less than 0 indicates that the link is less likely to occur in the patient group. In order to obtain the statistical significance of the score $S^{link}$ for a particular link, a permutation test was carried out (in which scores were created just on the assumption that the patients and controls were randomly allocated to a group).

In brief the rationale behind our approach for establishing functional connectivity changes is to measure the risk difference score for each link, and to test (using a permutation test) for each patient group which links have significantly different risk difference scores from the control group. We were able to validate the main findings obtained with this risk difference statistical approach by application of a false discovery rate (FDR) procedure to the whole brain 90 × 90 matrix of functional connectivity correlation values; and by application of a whole brain FDR procedure to identify link differences based on Fourier analyses of the time series of the two connected brain regions, as described in the [Results](#sec3){ref-type="sec"} section. The risk difference measure was selected for the analysis described here because patients who have not been treated with neuroleptic drugs are rare, and although we were able to gather 21 NNS patients for this group, we wished to use a measure that was potentially sensitive to differences when the group size is not very large. Having selected this measure, all the main results as part of the statistical approach were then validated by use of an FDR approach, as described in the "[Further analyses](#sec3.3){ref-type="sec"}" section.

3. Results {#sec3}
==========

3.1. Participant characteristics {#sec3.1}
--------------------------------

The participant characteristics for the three groups are shown in [Table 1](#t0005){ref-type="table"}. There were no significant differences as to the sex, and years of education between the three groups. The mean age of the groups was similar (HC = 27.2 years, NN = 24.8, NTS = 22.9 years) \[though the difference was significant (F = 5.176, p = 0.007), with a post-hoc test showing that the NTS group was significantly lower in age than the HC group only (LSD − t = 4.30, p = 0.002)\]. Illness course also showed no significant differences between the two patient groups. The sum scores for the different parts of the PANSS ([@bb0034]) were similar for the two patient groups, with values provided in the [Table 1](#t0005){ref-type="table"}. Significant differences between the two patient groups in 10 subscale scores of the PANSS ([@bb0034]) were present, including delusion, hostility, stereotyped thinking, anxiety, tension, mannerisms and posturing, uncooperativeness, poor impulse control and preoccupation (see details in [Table S2](#t1010){ref-type="table"}). Thus, consistent with previous studies ([@bb0033]; [@bb0058]; [@bb0061]), some of the positive symptoms were among those treated by the neuroleptics, and many of the cognitive and negative symptoms appeared to be treated less efficiently by the neuroleptic drugs.

3.2. Comparisons of functional connectivity maps between the three groups {#sec3.2}
-------------------------------------------------------------------------

Using permutation tests on the risk difference scores, 20 significantly altered links were identified in the NNS group and 19 in the NTS group, compared to the HC group ([Fig. 1](#f0005){ref-type="fig"} and [Table 2](#t0010){ref-type="table"}).

First the four altered functional connectivity links present in both NNS and NTS patients are considered. They are marked with rectangles in [Figs. 1 and 2](#f0005 f0010){ref-type="fig"}. We note that negative scores reflect a weaker functional connectivity link, and positive scores a stronger link, in a patient group relative to controls, as the score reflects patient group --- healthy controls. Links with negative scores (i.e. weaker functional connectivities in patients relative to controls) are shown in blue in [Fig. 1](#f0005){ref-type="fig"}, and stronger links in red.

The greatest reduction in functional connectivity in both NNS and NTS patients compared with HC is that between the posterior cingulate gyrus (PCG) and precuneus (PCUN) in the left hemisphere (s = −0.19 with p = 0.02 for NNS and s = −0.24 with p = 0.002 for NTS). Since both the PCG and PCUN are large in the human brain, to examine better the similarities of the changes in both patient groups, source location analyses for the altered voxels in these two regions were performed in NNS and NTS respectively (calculated as described in the [Appendix](#s2105){ref-type="sec"}). From [Fig. 3](#f0015){ref-type="fig"} (panel B and C), it can be seen that the locations of the altered voxels in the PCG and PCUN in the NNS patients were similar to those in the NTS patients.

The correlation analyses with the symptoms measured in the PANSS across all patients showed that the change in the PCG.L--PCUN.L link was significantly correlated with the disturbance of volition (r = 0.45, p = 0.002) ([Table 3](#t0015){ref-type="table"}), as well as with some of the other general symptoms within the PANSS, and the PANSS general and negative symptom subtotal scores. \[Since we were specifically interested in the common altered links in the two patient groups, to test the hypothesis that the common functional alterations in the two patient groups are correlated with cognitive and negative symptoms, correlation analyses were only performed between the 4 common altered links in both groups of patients and the clinical measures in the patients. This keeps the number of tests performed down to reasonable numbers, but as a precaution only effects that were significant at p \< 0.05 with FDR correction are shown in [Table 3](#t0015){ref-type="table"}. These are canonical correlations between the symptoms and the Fourier link coefficients based on the time series of the two connected brain regions, as described in the '[Further analyses](#sec3.3){ref-type="sec"}' section.\]

Three interhemispheric functional connections were also reduced in both patient groups: those between the middle temporal pole (TPOmid) (s = −0.17 with p = 0.03 for NNS and s = −0.28 with p = 0.00 for NTS), the superior orbitofrontal cortex (ORBsup) (s = −0.19 with p = 0.03 for NNS and s = −0.16 with p = 0.009 for NTS), and the amygdala (AMYG) (s = −0.17 with p = 0.02 for NNS and s = 0.21 with p = 0.001 for NTS) ([Fig. 2](#f0010){ref-type="fig"}), with additional statistical analyses confirming the significant reductions in the strength of these links after whole brain correction with FDR provided in the '[Further analyses](#sec3.3){ref-type="sec"}' section.

As an additional check that these four links were all reduced in both patient groups, a direct comparison of the functional maps between the two patient groups showed no significant differences between these common reduced functional connections, confirming that the weakened PCG--PCUN link and three interhemispheric links (bilateral ORBsup, AMYG and TPOmid) were commonly altered in both untreated and treated patients (p \> 0.05, [Table 2](#t0010){ref-type="table"} and [Fig. S2](#f9005){ref-type="fig"}).

The functional connectivity links that are different between the two patents groups are now considered. [Fig. 2](#f0010){ref-type="fig"} shows the different patterns of altered functional connectivity in the NNS and NTS patients. \[The resting state networks (RSN) shown on the right of [Fig. 2](#f0010){ref-type="fig"} are based on the constructed six-community structure for the whole brain from healthy subjects shown in [Fig. S1](#f7005){ref-type="fig"} in the [Appendix](#s2105){ref-type="sec"}, and was constructed using data from more than 400 healthy brains ([@bb0064]). These six communities have a clear biological significance which can be classified as the default mode network (DMN) (RNS1), the attention network (RSN2), the visual system (RSN3), the auditory system (RSN4), the sensory-motor areas (RSN5), and the sub-cortical network (RSN6).\] One difference evident in [Figs. 1 and 2](#f0005 f0010){ref-type="fig"} is that there were more strengthened functional connections in NNS patients relative to the controls, whereas there were more weakened connections in NTS patients relative to controls. The statistically significant differences between the NNS and the NTS groups are shown by + or − prescripts in [Table 2](#t0010){ref-type="table"}, and the differences are indicated in [Fig. S2](#f9005){ref-type="fig"}.

The altered functional connectivity in the NNS group was mainly in fronto-parietal circuits and subcortical circuits (see [Fig. 2A](#f0010){ref-type="fig"}). The abnormal fronto-parietal circuits were composed of three different neural pathways, including a circuit (i.e. a set of altered connected functional links) involving the dorsal superior frontal gyrus (SFGdor), middle frontal gyrus (MFG), and inferior parietal lobule (IPL); a circuit involving the inferior obitofrontal cortex (ORBinf), opercular inferior frontal gyrus (IFGoper), triangular inferior frontal gyrus (IFGtriang) and supramarginal gyrus (SMG); and a circuit involving the medial superior frontal gyrus (SFGmed) and angular gyrus (ANG) (see [Fig. 2A](#f0010){ref-type="fig"}). The subcortical circuits included a striato-thalamic circuit involving the putamen (PUT), pallidus (PAL) and thalamus (THA); and a hippocampo-parahippocampal circuit. In addition, an insula-rolandic-superior temporal circuit in the auditory network, a circuit in the sensorimotor network involving precentral gyrus (PreCG) and supplementary motor area (SMG), and a circuit in the visual network involving middle occipital gyrus (MOG) and inferior occipital gyrus (IOG) were also identified as discrepant in the NNS patients (see [Fig. 2A](#f0010){ref-type="fig"}).

The altered functional connectivity in the NTS group was mainly in a prefronto-sensorimotor circuit involving IFGoper, PreCG and postcentral gyrus (PoCG); and a sriato-insular circuit involving PUT and insula (INS) (see [Fig. 2B](#f0010){ref-type="fig"}). Further, it is noteworthy that the abnormal interhemispheric connectivity was more widespread and weakened in the NTS group than the NNS group (see [Fig. 2B](#f0010){ref-type="fig"}).

3.3. Further analyses {#sec3.3}
---------------------

Further analyses were performed to validate the findings obtained with the risk difference analyses performed. In particular, a false discovery rate (FDR) analysis ([@bb0023]) was applied to the whole brain 90 × 90 binarized correlation matrix of functional connectivities.

For the NTS group, the majority of the links shown in [Table 2](#t0010){ref-type="table"} as significant in the risk difference analysis resulted in significant effects in the same direction with the FDR analysis with q = 0.05 (the one-tailed significance level given the prior hypothesis from the permutation test) for which the statistical threshold was p = 0.0260. For example, the following links were confirmed as significantly different between the NTS and the control groups using the FDR approach: INS.R--PUT.R; TPOmid.L--IFGtriang.R; IFGtriang.L--IFGtriang.R; PCG.L--PCUN.L; AMYG.L--AMYG.R; PreCG.L--PoCG.L; PreCG.L-- PreCG.R; PAL.L--PAL.R; HIP.L--HIP.R; PHG.L--PHG.R. This additional analysis thus helps to validate some of the main conclusions of the paper, including the reduced functional connectivity for the PCG.L--PCUN.L link (p = 0.003 in the FDR analysis) in the NTS patients, and some of the reduced interhemispheric links including those between the two amygdalae, and the two temporal poles.

For the FDR analysis in the NNS group the statistical threshold was p = 0.0081 as the number of patients was smaller, but nevertheless the functional connectivities shown in [Table 2](#t0010){ref-type="table"} for the NNS group that were significantly different from controls included the following, in line with the risk-difference analyses: HIP.L-PHG.R; ROL.R-STG.R; SFGdor.L-MFG.L; MFG.R-IPL.R; and IFGoperc.L- IFGtriang.L.

We performed an additional analysis to validate the identification of the links in [Table 2](#t0010){ref-type="table"} that were common between the NTS and NNS patents as being reduced relative to controls. We did this by performing a statistical test that was whole brain corrected using FDR to identify which links in the combined NTS and NNS groups (83 patients) were different from the links in the controls. The FDR threshold for significance at p \< 0.05 (two-tailed) across the whole brain was 0.0166, and all four common links were more significant than this threshold value of significance as follows. PCG--PCUN p = 4.18 × 10^−4^; AMYG.L-AMYG.R *p* = 2.5 × 10^−4^; TPOmid.L-TPOmid.R p = 0.0012; ORBsup.L-ORBsup.R p = 0.02. Thus all four links shown as common in being reduced in NTS and NNS patients in [Table 2](#t0010){ref-type="table"} were found to be different using a whole brain FDR correction performed on the combined NNS and NTS groups vs controls. This is useful validation, for the links include links relevant to the association between avolition and the PCG--PCUN link described in the main text; and between the negative symptoms and the AMYG.L-AMYG.R, TPOmid.L-TPOmid.R, and the ORBsup.L-ORBsup.R links. To perform the correlations between these links and the symptoms, the following method was used. The correlation coefficient between the time series for two brain regions was replaced with a Fisher combined probability calculated across the Fourier coefficients of the correlations between the 2 time series from the two regions being analyzed ([@bb0099]). In more detail, we converted the 170-point time series with samples every 2 s from each subject into 17 segments each 10 time-points long, and calculated the Pearson correlation for each segment. The Fourier coefficients of this 17-segment time series of Pearson correlations was calculated. This algorithm provides a measure of the variation of the link correlations across the segments of the resting state time series. The Fourier coefficients that maximized the canonical correlation with the symptoms were used. In practice, the use of two Fourier coefficients did show significant correlations with the symptoms for the the PCG.L--PCUN.L link, as shown in [Table 3](#t0015){ref-type="table"}.

4. Discussion {#sec4}
=============

Features of the present study are that it used a whole-brain functional connectivity approach, and that it compared untreated patients with first-episode schizophrenia (NNS), with patients with first-episode schizophrenia treated with neuroleptic drugs (NTS), and with controls.

First we discuss the brain functional connectivity changes that were common to the two patient groups, involving the weakened PCG--PCUN coupling and some weakened interhemispheric couplings, as they are of great interest for understanding the neuropathophysiology of schizophrenia.

The PCG (posterior cingulate gyrus) and PCUN (precuneus), broadly known as the key nodes in the so-called "default mode network" (DMN) ([@bb009]; [@bb0021]), are both located in the posterior medial parietal area. Importantly, within this area, the PCG and PCUN are reciprocally and strongly anatomically interconnected ([@bb0010]; [@bb0067]), providing a robust anatomical basis for their functional connectivity analyzed here. Consistent with our finding, there have been many resting-state and task-related fMRI studies showing abnormal functions in the PCG and PCUN ([@bb007]; [@bb0043]; [@bb0069]). Our subsequent source location analysis ([Fig. 3](#f0015){ref-type="fig"}) found that the exact voxels with altered connectivity in the PCG and PCUN in the NNS patients were quite similar to those in the NTS patients, confirming that the PCG--PCUN circuit changed commonly in the two patient groups. Therefore, it may be inferred that the reduced functional connectivity between PCG and PCUN, identified in both the treated and untreated patients in the present study, has extended previous evidence that the functional deficits in the PCG--PCUN circuit are not only critical in the pathophysiology of schizophrenia, but also are possibly resistant to current neuroleptic drugs. Consistent with this view, the altered functional connectivity in the default mode network in schizophrenia was not changed by 6 weeks of antipsychotic treatment ([@bb0041]).

Our subsequent correlation analysis showed a significant association between the weakened PCG--PCUN link and the reduced volition. Disturbances of volition as measured in this investigation using the PANSS scales include disturbances of the self-initiation, maintenance, and control of one\'s speech, thoughts, movements and behavior ([@bb0034]). That is, avolition in this sense describes a disturbance of the way in which the self is normally perceived as being involved as the agent that initiates speech, thoughts, movements and behavior. The precuneus and the posterior cingulate cortex have been described as being involved in consciousness of the self, and as having high activity when humans are engaged in self-related mental representations during rest ([@bb0010]). This evidence is consistent with and supports our finding that functional impairments in the PCG/PCUN region are correlated in schizophrenia with dysfunctions in the sense of self and self-control ([@bb0049]), such as the volitional deficits. Consistent with this proposal, the volitional deficits shown by patients with damage to various parts of the cingulate gyrus have been related to impairment of the core self ([@bb0015]). Indeed, recent fMRI studies have revealed abnormal brain activity and reduced functional connectivity in the PCG and PCUN in schizophrenic patients during self-referential processing and the resting state ([@bb007]; [@bb0024]; [@bb0037]; [@bb0043]; [@bb0066]), providing further evidence of the finding reported here of reduced volition associated with reduced functional connectivity between the PCG and PCUN in untreated patients with schizophrenia and also in patients treated with antipsychotics. An implication is that a treatment other than conventional antipsychotic drugs is needed to restore the sense of self and of control in schizophrenia. It was further found that the reduced functional connectivity in the PCG.L--PCUN.L link was associated with other general symptoms (including the general subtotal score of the PANSS) and with several of the negative symptoms of schizophrenia, but not with the positive symptom subtotal score of the PANSS ([Table 3](#t0015){ref-type="table"}). The same observation applies that treatments other than conventional antipsychotic drugs may be needed to treat these other general and negative symptoms of schizophrenia ([@bb0054]; [@bb0057]).

Another important common feature of the functional alteration in the two patient groups is the reduced interhemispheric connectivity involving bilaterally the amygdalae, orbitofrontal cortex, and temporal pole. This is of interest, for it has been proposed that the lateralized abnormality in schizophrenia can be explained either by hemisphere dysfunction, or by impaired interhemispheric coupling, leading to a failure of the dominant hemisphere to over-rule non-dominant homologous areas ([@bb003]; [@bb005]). Functional connectivity analyses have demonstrated interhemispheric disconnection in the language cortex, particularly Broca\'s area in the prefrontal cortex ([@bb004]; [@bb006]). More evidence for this long-standing abnormal asymmetry hypothesis in schizophrenia comes from tract-tracing and automated imaging studies, which have consistently demonstrated the impaired integrity of white matter (WM) fibers interconnecting the two hemispheres, such as the corpus callosum (CC) and anterior commissure (AC) ([@bb0012]; [@bb0027]; [@bb0030]; [@bb0050]). In particular, the AC, which connects between the hemispheres the amygdalae, anterior temporal area, and the orbitofrontal cortex ([@bb0016]; [@bb0027]), has been reported to be impaired in both fiber density and WM integrity by post-mortem and diffusion tensor imaging (DTI) studies in schizophrenia ([@bb0012]; [@bb0027]). It is interesting to note that our finding of these weakened interhemispheric couplings has extended the evidence from anatomical disconnection to functional disconnection in the areas interconnected by the AC.

Furthermore, the impaired interhemispheric functional connectivity involving the amygdalae, anterior temporal area, and the orbitofrontal cortex may be related to the negative symptoms in schizophrenia, as these regions are involved in emotion and motivation ([@bb0056; @bb0055]). Importantly, previous studies have suggested little effectiveness of pharmacological treatments on the negative symptoms ([@bb0033]; [@bb0058]; [@bb0061]). Thus new agents targeting these interhemispheric uncouplings involved in emotional and motivational processing may help towards better functional recovery for patients with schizophrenia.

Taken together, these common brain alterations in the NNS and NTS patients, in combination with their associations with volitional deficits and negative symptoms, suggest current pharmacological treatment may have less efficiency on the volitional deficits and negative symptoms, and their related neurophysiological deficits in the schizophrenia patients. These points thus lead us to suggest that our findings may provide a clue for new pharmacological agents to target the negative symptoms and volitional deficits and their related neurophysiological substrates in schizophrenia.

The present study, by applying a whole-brain functional connectivity approach, also showed different patterns of functional deficits between the untreated and treated patients, which may provide further insight into the medication effects on the functional connectivity in the brain of patients with schizophrenia. We found that in the NNS patients, functional connectivity was increased in hippocampal (PHG-HIP) and auditory cortical (STG) links, and in fronto-parietal circuits (the SFGdor-MFG-IPL circuit and ORBinf-IFGoper-IFGtriang-SMG circuit) and subcortical circuits (the striato-thalamic circuit and hippocampo-parahippocampal circuit), and became closer to normal in the NTS patients ([Fig. 1](#f0005){ref-type="fig"}). The hippocampal/temporal lobe connectivity may be related to the positive symptoms of schizophrenia, the fronto-parietal circuits may be related with the deficits of decision-making, working memory and attention in schizophrenia ([@bb0063]), and the strengthened subcortical striato-thalamic circuit is believed to be closely related to the pathology of schizophrenia ([@bb0045]) and to the effects of antipsychotic drugs ([@bb0026]). These findings are consistent with a follow-up resting-state fMRI study, in which it was found that the abnormal frontoparietal and striatal functions were normalized by antipsychotic medication for 6 weeks ([@bb0041]). This restoration by the dopamine D2 receptor blockade produced by anti-psychotic treatment may facilitate the effects of GABA, and thus reduce the increased functional connectivity found in these circuits in the untreated patients with schizophrenia ([@bb0054]; [@bb0057]). However, although altered connectivity of the superior temporal gyrus (STG) has been consistently demonstrated as correlated with hallucinations in schizophrenia ([@bb0028]; [@bb0059]), in the present study, hallucinations were not different between the NNS (Mean ± SD: 3.84 ± 1.31) and NTS (Mean ± SD: 3.56 ± 1.61) patients.

However, although altered connectivity of the superior temporal gyrus (STG) has been consistently demonstrated as correlated with hallucinations in schizophrenia ([@bb0052]; [@bb0053]), in the present study, hallucinations were not different between the NNS (Mean ± SD: 3.84 ± 1.31) and NTS (Mean ± SD: 3.56 ± 1.61) patients.

The present study applying a whole-brain functional connectivity analysis enables us to reveal a broadly distributed dysconnectivity pattern across large-scale brain networks in schizophrenia, lending further support to the notion of a diffuse dysregulation of neural dynamics in this disorder ([@bb0019]). Our observation, that most of the increased functional connectivity in the neuroleptic-naïve (NNS) patients appears to be normalized in the neuroleptic-treated (NTS) patients, has highlighted the important potential contribution of medication effects to the conflicting findings of both increased and decreased functional connectivity in previous studies ([@bb0051]). Moreover, at the brain-network level the impaired circuits in the posterior Default Mode Network and emotion-processing system that were not influenced by treatment with neuroleptics may provide new drug targets for the negative symptoms, which are not treated well with current antipsychotics. Additional implications of the present study for future studies include the following. First, our neuroleptic-treated patients showed only a trend towards reduction of the positive symptoms compared to the untreated patients, so in future studies it could be of interest to study patients at different stages of their treatment with neuroleptics. (In the present study, 21 NTS patients had an illness duration of less than 6 months, and 28 had an illness duration of less than 12 months. The duration of treatment of the NTS group was in the range 2--144 weeks, with a median of 32 weeks.) Second, the clinical symptoms of the schizophrenic patients in the present study were measured with the PANSS ([@bb0034]). The three-factor structure (Positive, Negative and General Psychopathology Symptoms) of the PANSS, however, may need some revision. For example, for the "disturbance of volition" included as G13, a body of evidence has suggested that this item should be considered with the Negative symptoms ([@bb0017]; [@bb0035]; [@bb0038]; [@bb0042]), and may be similar to the "avolition" in another psychopathology assessment scale SANS ([@bb002]). Moreover, the description of G13 appears to emphasize indecisiveness which may not relate only to volitional deficits but also to cognitive impairments such as disrupted attentional control. Thus, further research on the link between volition and PCC-PCUN functional connectivity might incorporate more detailed measures of volition. Third, in the present study we were not able to compare the effects on functional connectivity of typical and atypical neuroleptics, as only 9 patients received first generation (typical) antipsychotic medication, and this comparison might be of interest for future studies.

In conclusion, the present study, by applying a whole-brain functional connectivity approach, revealed decreased functional connectivity in the precuneus--parahippocampal connectivity that was associated with the decrease in the sense of the self being in control (decreased volition); and a decrease in interhemispheric connectivity between temporal lobe structures involved in emotion that was related to the negative symptoms of schizophrenia. This reduced connectivity, and the related volition and negative symptoms, were not treated by the antipsychotic drugs used in the NTS group. An implication is that treatments that increase this connectivity, such as treatments that restore the hypoglutamatergia of schizophrenia ([@bb0013]; [@bb0014]), might treat these symptoms of schizophrenia ([@bb0054]; [@bb0057]). The increased functional connectivity found in hippocampal and auditory circuits may be related to the positive symptoms of schizophrenia, and were reduced by the antipsychotic treatment, which may have produced this change by the D2 receptor blockade which can facilitate the actions of the inhibitory transmitter GABA ([@bb0054]; [@bb0057]). In addition, the results described here inform our basic understanding of brain structure--function relations by providing new evidence on the relation between the precuneus and posterior cingulate gyrus and volition, understood as the willful initiation, sustenance, and control of thoughts, behavior, movements, and speech; and on how reduced interhemispheric functional connectivity between brain structures such as the amygdala, orbitofrontal cortex, and temporal pole could be related to reductions in emotion and motivation that relate to the negative symptoms of schizophrenia, emotional withdrawal, and depression.

 {#s2105}

Inclusion and Exclusion Criterion for the Participants {#s4410}
------------------------------------------------------

Twenty-two neuroleptic-naïve schizophrenic patients (NNS) and sixty-one neuroleptic-treated schizophrenia patients (NTS) were recruited from the Department of Psychiatry of the Second Xiangya Hospital of Central South University, Changsha, China. All participants were diagnosed with schizophrenia using the Structural Clinical Interview for DSM-IV, Patient version (SCID-I/P) and met the following inclusion criteria: 1) 18-45 years of age; 2) Han Chinese ethnicity; and 3) right handedness. Participants were excluded if they had: 1) a history of substance-related disorders; 2) a history of neurological illness or other serious physical illness; 3) a contraindication for MRI; or 4) a history of electroconvulsive therapy. The patients in the two groups were similar, except that the research described here was performed in the NNS group before treatment started.

Sixty healthy controls (HC), including 35 males and 25 females, were recruited from Changsha, China. The inclusion and exclusion criteria for HC were the same as those for the schizophrenic patients other than the DSM-IV diagnostic criteria. Individuals with a family history of psychiatric illness among their first-degree relatives were excluded from the HC group.

The PANSS ([@bb0034]) sum scores for the NNS vs NTS groups showed no significant differences, and for the PANSS positive sum score were 22.5±6.2 vs 19.0±6.2 (mean±sd); for the PANSS negative sum score were 22.7±10.3 vs 21.2±6.7; for the PANSS general psychiatric sum score were 42.4±14.9 vs 38.2±10.5; and for the PANSS sum score were 92.3±31.8 vs 85.1±20.3). It is noted that the positive symptom sum score showed a trend-level difference (*t*=-1.89, p=0.06) between the two patient groups.

Medication Dosage and Duration of Neuroleptic-treated Patients {#s1015}
--------------------------------------------------------------

All the NTS patients were taking antipsychotics at the time of scanning: nine patients (15%) were receiving first generation antipsychotics (FGAs) (sulpiride, 7 cases; and haloperidol, 2 cases); forty two patients (69%) were receiving second generation antipsychotics (SGAs) (clozapine, 7 cases; risperidone, 19 cases; quetiapine, 10 cases; olanzapine, 6 cases), and ten patients (16%) were receiving combination therapy (combining an FGA and an SGA, 4 cases; and combining an SGA and an SGA, 6 cases). All medication doses were converted to chlorpromazine equivalence (50\~1500 mg/day). The mean dosages of treatments with FGAs, SGAs and combination therapy were 822.9 mg/day, 384.6 mg/day and 572.3 mg/day respectively. Moreover, the mean medication duration of the NTS patients was 36.8 weeks (2 \~ 144 weeks).

Image acquisition {#s2020}
-----------------

All subjects underwent structural and functional MRI scanning using the same 1.5-T GE Signa Twinspeed MR scanner (General Electric Medical System, Milwaukee, USA). A standard head coil was used for radio frequency transmission and reception of the nuclear magnetic resonance signal. Foam pads and ear plugs were used to minimize head motion and scanner noise. All the subjects were instructed to keep their eyes closed, not to think about anything in particular and to move as little as possible. 3-D structural MRI images (T1-weighted) were acquired from the sagittal plane using spoiled gradient echo (SPGR) pulse sequence, scanning parameter: TR = 12 ms, TE = 4.2 ms, flip angle = 15°, 172 slices, matrix size = 256 × 256, and the field of view (FOV) = 24 × 24 cm. Slices were contiguous with slice thickness of 1.8mm. Functional images were acquired by using a gradient-echo echo-planar imaging sequence sensitive to BOLD signal (TR/TE = 2000/40 ms, flip angle = 90°, FOV = 24 × 24 cm). Whole-brain volumes were acquired with 20 contiguous 5mm thick transverse slices with a 1mm gap and 3.75 × 3.75 mm in-plane resolution. For each subject, fMRI scanning lasted for 6 minutes and 180 volumes were obtained.

Functional Imaging data preprocessing {#s1225}
-------------------------------------

Before preprocessing, the first 10 volumes were discarded to allow for scanner stabilization and the subjects' adaptation to the environment. fMRI data preprocessing was then conducted by SPM5 (University College London, UK; <http://www.fil.ion.ucl.ac.uk/spm>) and DPARSF (Data Processing Assistant for resting-state fMRI). The remaining functional scans were quickly corrected for within-scan acquisition time differences between slices, and then realigned to the middle volume to correct for interscan head motion. Subsequently, the functional scans were spatially normalized to a standard template (Montreal Neurological Institute) and re-sampled to 3 × 3 × 3 mm. After normalization, the Blood Oxygenation Level Dependent (BOLD) signal of each voxel was first detrended to remove the linear trend and then passed through a band-pass filter (0.01-0.08 Hz) to reduce low-frequency drift and high-frequency physiological noise. In addition to band-pass filtering and correcting for movements, additional preprocessing steps, such as global signal regression ([@bb9990]), were performed. Global signal regression may lead to artefactual negative correlations, but this technique was used because it is suggested to improve the specificity of positive correlations and can remove specific confounds from the data to facilitate the evaluation of neurophysiological relationships, helping to make the data more readily or reliably interpretable ([@bb9990]). We note that there is recent evidence that the global brain signal is altered in schizophrenia ([@bb7770]). Thus, nuisance covariates, including head motion parameters, global mean signals, white matter signals and cerebrospinal fluid signals were regressed out from the Blood Oxygenation Level Dependent (BOLD) signals.

Voxel Location {#s4430}
--------------

In order to detect the location of the voxels in the PCG and PCUN regions which show significant differences between patients and healthy controls ([Fig. 3](#f0015){ref-type="fig"}), Pearson correlation coefficients between all pairs of voxels of the PCG-PCUN link were first calculated, then a Fisher's r-to-z transformation was utilized to convert each correlation coefficient *r*~*ij*~ into *Z*~*ij*~ to improve the normality. After Fisher's r-to-z transformation, two-sample t-tests were performed for all inter-voxel correlation coefficients. A significance level of p \< 0.05 was used to specify the source voxels within this regional link. To identify dysfunctional voxels, for each selected voxel *i* in region A, a dysfunction intensity for this voxel was defined as follows:$$\mathit{Intensity}\left( i \right) = \frac{N_{i}^{B}}{N^{B}}$$where *N*~*i*~^*B*^ is the number of voxels in region B that show significantly different (p\<0.05) functional connectivity with the selected voxel *i* in region A compared with normal controls. *N*^*B*^ is the total number of voxels in region B. This is reasonable since the value of intensity represents the significance of the changed correlation for each voxel. An intensity level (intensity\>0.32) was further used to threshold voxels into two groups of voxels (unchanged and changed).Table S1The Names and Abbreviations of the Regions of Interest (ROIs).Regions Abbr.RegionsAbbr.AmygdalaAMYGOrbitofrontal cortex (middle)ORBmidAngular gyrusANGOrbitofrontal cortex (superior)ORBsupAnterior cingulate gyrusACGPallidumPALCalcarine cortexCALParacentral lobulePCLCaudateCAUParahippocampal gyrusPHGCuneusCUNPostcentral gyrusPoCGFusiform gyrusFFGPosterior cingulate gyrusPCGHeschlgyrusHESPrecentral gyrusPreCGHippocampusHIPPrecuneusPCUNInferior occipital gyrusIOGPutamenPUTInferior frontal gyrus (opercula)IFGopercRectus gyrusRECInferior frontal gyrus(triangular)IFGtriangRolandic operculumROLInferior parietal lobuleIPLSuperior occipital gyrusSOGInferior temporal gyrusITGSuperior frontal gyrus (dorsal)SFGdorInsulaINSSuperior frontal gyrus (medial)SFGmedLingual gyrusLINGSuperior parietal gyrusSPGMiddle cingulate gyrusMCGSuperior temporal gyrusSTGMiddle occipital gyrusMOGSupplementary motor areaSMAMiddle frontal gyrusMFGSupramarginal gyrusSMGMiddle temporal gyrusMTGTemporal pole (middle)TPOmidOlfactoryOLFTemporal pole (superior)TPOsupOrbitofrontal cortex (inferior)ORBinfThalamusTHAOrbitofrontal cortex (medial)ORBmedTable S2Significant Differences of PANSS Sub-scales between Neuroleptic-naïve Patients and Neuroleptic-treated Patients.VariablesNNS (N=22)NTS (N=61)MeanSDMeanSDDelusion score4.82.03.71.4Hostility score2.61.11.81.0Stereotyped thinking score2.31.31.50.7Anxiety score3.41.32.61.1Tension score3.01.42.31.0mannerisms and posturing score2.71.52.00.9Uncooperativeness score2.41.21.60.9Poor impulse control score3.41.62.41.2Preoccupation score3.11.42.31.2[^2]

Fig. S1.a. Community structure derived from normal healthy subjects ([@bb0064]). b. The correlation coefficient matrix of the BOLD signals from 90 ROIs of one randomly selected subject. c. (Left) Medial view of the surface of the brain. (Right) The lateral view of the surface of the brain. Different colors represent different communities.

Fig. S2Differences in functional connectivity maps between neuroleptic-naïve and neuroleptic-treated schizophrenia patients. The red lines indicate links strengthened in NNS patients and blue lines indicate links weakened in NNS patients, compared to NTS patients. The line thickness indicates the difference magnitude of the connection strength between the two patient groups. The common altered links in the two patient groups shown include the precuneus-posterior cingulate cortex link, and three interhemispheric links (bilateral orbitofrontal cortex, amygdalae and temporal pole). These links showed no significant differences (p\>0.05) between the two patient groups.
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![A. Bar plot of the risk difference scores of the functional connectivity links in NNS patients relative to healthy controls. Negative scores reflect weaker links and are shown in blue, while positive scores reflect stronger links and are shown in red. B. The corresponding plots for the NTS patient group. Common altered links in NNS and NTS patient groups are marked with green rectangles.](gr1){#f0005}

![Panels A and B show the altered links in neuroleptic-naïve patients (NNS) and neuroleptic-treated patients (NTS) relative to the healthy controls (HC) respectively: A(1) and B(1) show the locations of these altered links in a transverse plane of the brain; A(2) and B(2) show the locations of these altered links in six communities of resting state networks (RSN) in different colors. Twenty links in the NNS and nineteen links in the NTS patients were found to be altered. Red lines: links increased in patients; blue lines: links reduced in patients; looped links are to the contralateral side. Line thickness corresponds to the score s. The common altered links in NNS and NTS patients are marked with green rectangles.](gr2){#f0010}

![Source location of the common altered links in neuroleptic-naïve and neuroleptic-treated schizophrenia patients. Panel A shows the locations of the common altered links in both patient groups on a brain template. Panels B and C show the source locations of the altered voxels in PCG and PCUN respectively, in which the right column illustrates the locations for NNS group, and the left column for the NTS group. Warm colors show is the altered voxels in the PCG and PCUN, and the blue colors show the unchanged voxels relative to healthy controls. The center voxels in the PCG and PCUN are denoted by red dots.](gr3){#f0015}

###### 

Sociodemographic and clinical variables of healthy controls, neuroleptic-naïve and neuroleptic-treated schizophrenia patients.

  -------------------------------------------------------------------------------------------------------------
  Variables                                  HC\          NNS\          NTS\          Statistical test   
                                             (n = 60)     (n = 22)      (n = 61)                         
  ------------------------------------------ ------------ ------------- ------------- ------------------ ------
  Sex, No. M/F                               35/25        14/8          35/26         .27                .87

  Age (SD), years                            27.2 (6.6)   24.8 (8.6)    22.9 (7.5)    5.18               .007

  Education (SD), years                      13.5 (3.2)   12.6 (3.2)    13.5 (2.6)    1.83               .16

  Course (SD), months                        −            12.3 (16.0)   18.1 (16.1)   1.4                .16

  PANSS positive sum score (SD)              −            22.5 (6.2)    19.0 (6.2)    −1.89              .06

  PANSS negative sum score (SD)              −            22.7 (10.3)   21.2 (6.7)    −.63               .53

  PANSS general psychiatric sum score (SD)                42.5 (14.9)   38.2 (10.5)   −1.23              .23

  PANSS sum score (SD)                       −            92.3 (31.8)   85.1 (20.3)   −1.16              .25
  -------------------------------------------------------------------------------------------------------------

Note: HC, healthy controls; NNS, neuroleptic-naïve schizophrenia; NTS, neuroleptic-treated schizophrenia; PANSS, positive and negative syndrome scale; SD, standard deviation.

###### 

Functional connectivity links that are different relative to controls in neuroleptic-treated (NTS) and neuroleptic-naïve (NNS) first-episode schizophrenic patients.

  Discrepant functional links in NTS patients   Discrepant functional links in NNS patients                                                             
  --------------------------------------------- --------------------------------------------- ------ -------- ------------------------- -------- ------ --------
  Ins.R--PUT.R                                  −0.320                                        .000   −0.058   +HIP.L--PHG.R             0.358    .000   0.072
  TPOmid.L--TPOmid.R                            −0.276                                        .000   −0.145   ROL.R--STG.R              0.303    .001   0.122
  IFGtriang.L-- IFGtriang.R                     −0.242                                        .002   −0.061   -ROL.R--INS.R             −0.270   .007   −0.078
  PCG.L--PCUN.L                                 −0.239                                        .002   −0.063   MOG.L--IOG.L              0.265    0.01   0.073
  AMYG.L--AMYG.R                                −0.211                                        .001   −0.119   +IFGoperc.R--SMG.R        0.265    .006   0.053
  PreCG.L--PoCG.L                               −0.207                                        .008   −0.058   SFGdor.L--MFG.L           0.242    .005   0.119
  +PreCG.L--PreCG.R                             −0.194                                        .003   −0.071   ROL.L--INS.L              −0.242   .006   −0.073
  -PreCG.L--IFGoperc.L                          0.191                                         .020   0.077    +SFGmed.L--ANG.L          0.239    .018   0.048
  SFGmed.L--ANG.L                               −0.189                                        .011   −0.072   MFG.R--IPL.R              −0.217   .021   −0.125
  +IPL.L--IPL.R                                 −0.162                                        .006   −0.047   PreCG.R--SMA.R            0.211    .018   0.052
  ORBsup.L--ORBsup.R                            −0.160                                        .009   −0.070   +SFGdor.R--MFG.R          0.209    .009   0.105
  SOG.L--MOG.L                                  0.152                                         .015   0.079    +PAL.L--THA.L             0.208    .022   0.032
  SOG.L--SOG.R                                  −0.146                                        .005   −0.069   ROL.L--ROL.R              −0.206   .002   −0.072
  PAL.L--PAL.R                                  −0.144                                        .028   −0.062   +IFGtriang.L--ORBinf.L    0.194    .029   0.064
  SPG.R--IPL.R                                  −0.143                                        .028   −0.024   ORBsup.L--ORBsup.R        −0.192   .029   −0.078
  ORBsup.L--ORBmid.L                            0.136                                         .020   0.076    PCG.L--PCUN.L             −0.191   .022   −0.070
  HES.L--STG.L                                  0.134                                         .007   0.041    AMYG.L--AMYG.R            −0.173   .016   −0.115
  HIP.L--HIP.R                                  −0.129                                        .024   −0.091   +PUT.R--PAL.R             0.171    .006   0.043
  PHG.L--PHG.R                                  −0.114                                        .002   −0.063   TPOmid.L--TPOmid.R        −0.168   .030   −0.114
                                                                                                              IFGoperc.L--IFGtriang.L   −0.120   .002   −0.091

Note: the positive scores reflect a greater proportion of patients than healthy controls with functional connectivity more significant than the binarization threshold (p = 0.01 for the partial correlation) for that link than controls, and negative scores a smaller proportion of patients with functional connectivity more significant than the binarization threshold than healthy controls. The scores were calculated with the equation described in the [Methods](#sec2){ref-type="sec"} section. The significance level for the risk difference p-value was set at p \< 0.03. NTS: neuroleptic-treated schizophrenia; NNS, neuroleptic-naïve schizophrenia The names and abbreviations of the regions of interest are shown in [Table S2](#t1010){ref-type="table"}.

− This indicates that there were fewer (p \< 0.05) binarized links (with the binarization at p \< 0.01) in the NNS than in the NTS group as shown by a permutation test.

\+ This indicates that there were more (p \< 0.05) binarized links in the NNS than in the NTS group as shown by a permutation test.

NTS-HC shows the value of the functional connectivity (measured by the partial correlation coefficients obtained from the resting state fMRI analysis) in the NTS group minus that in the healthy control group. A negative value thus shows a weaker functional connectivity in the NTS group than in the healthy control group. NNS-HC: the same for the functional connectivity in the NNS group minus that in the healthy control group.To help with the interpretation, all the functional connectivity values for the links in the table were positive, and the mean value of the functional connectivity for the healthy controls across these links in Table 2 was 0.31 (which was the mean of the partial correlation coefficients). Further, a negative risk difference score for a patient group --- HC reflects a lower positive functional connectivity correlation value for a link in a patient group than in the HC group.

###### 

Associations of clinical variables with the common altered links in both patient groups.

  ROIs               Clinical variables                  Correlation   p-Value
  ------------------ ----------------------------------- ------------- --------------
  PCG. L -- PCUN.L   PANSS general sum score             0.445         0.0015
                     PANSS negative score                0.454         0.0011
                     Disturbance of volition G13         0.448         0.002
                     Uncooperativeness G8                0.623         1.3 × 10^−6^
                     Unusual thought content G9          0.455         0.001
                     Lack of judgement and insight G12   0.488         0.0006
                     Hostility P7                        0.5853        9.7 × 10^−6^

Note: see names and abbreviations of the region of interest in [Table S1](#t1005){ref-type="table"}.

All the results shown were significant with p \< 0.05 after FDR corrected for multiple comparisons.

[^1]: WD Pu, ET Rolls and SX Guo contributed equally to this work.

[^2]: Note: NNS, neuroleptic-naïve schizophrenia; NTS neuroleptic-treated schizophrenia; PANSS, positive and negative syndrome scale; SD, standard deviation.
